Pharmaceutical

Atypical Teratoid Rhabdoid Tumor drugs in development, 2024

GlobalData tracks 18 drugs in development for Atypical Teratoid Rhabdoid Tumor by 16 companies/universities/institutes. The top development phase for Atypical Teratoid Rhabdoid Tumor is preclinical, with six drugs in that stage.

Aug 31, 2024 - 04:00
GlobalData tracks 18 drugs in development for Atypical Teratoid Rhabdoid Tumor by 16 companies/universities/institutes. The top development phase for Atypical Teratoid Rhabdoid Tumor is preclinical, with six drugs in that stage.
Read the original article

Tags:

Previous Article

Non-infectious Uveitis drugs in development, 2024

Next Article

Generalized Pustular Psoriasis (GPP) drugs in development, 2024

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

FDA rejects Alvotech’s Humira biosimilar for the third time

FDA rejects Alvotech’s Humira biosimilar for the third ...

Jun 29, 2023

Sen. Bernie Sanders moves toward another hearing with pharma CEOs

Sen. Bernie Sanders moves toward another hearing with p...

Nov 7, 2023

Why it won’t be so easy for medicine to displace BMI

Why it won’t be so easy for medicine to displace BMI

Jun 16, 2023